Dec 7, 2018

WestView Capital Partners Exits Investment in Thorne Wednesday, October 10, 2018 New York, NY – Thorne today announced that WestView Capital Partners and Tudor Ventures have exited their investment in the Company as part of a recapitalization and joint strategic investment in the Company made by Mitsui & Co., Ltd. (Mitsui) and Kirin Holdings Company, Limited (Kirin). The joint investment between Kirin and Mitsui will be used to help expand Thorne’s personalized health technology platform and products and to jointly grow their businesses in Asia. This follows Mitsui’s investment in Thorne late last year. Thorne is a leading developer and manufacturer of high-quality, premium supplements sold primarily through medical professionals and also directly to consumers. For over 30 years, Thorne has been dedicated to enhancing the health and well-being of people worldwide by providing innovative, research-based nutritional supplements, personalized nutrition and technology-enabled medical education. Thorne is the only supplement manufacturer to collaborate with the Mayo Clinic on wellness research and content and is the proud partner of a number of U.S. National Teams, including U.S. Soccer, USA Hockey and USA Triathlon. “The Thorne team would like to thank WestView Capital Partners and Tudor Ventures for their support in helping us triple the size of the company during their tenure as investors, and we look forward to substantial growth in our new 270,000 square foot facility just outside Charleston, South Carolina, with Mitsui, Kirin and existing investor, Helsinn Group, as our investors going forward,” stated Paul Jacobson, Thorne’s CEO. “Paul and the Thorne team did a great job accelerating the growth of Thorne and realizing key strategic objectives including establishing partnerships with leading medical and wellness organizations,” said Rick Williams, a Managing Partner at WestView Capital Partners. “Their vision and commitment to the forefront of quality, efficacy and innovation in supplements have created an industry leading organization we are proud to have partnered with” added Williams. About Thorne Thorne is a leading developer and manufacturer of high-quality, premium supplements. For over 30 years, Thorne has been dedicated to enhancing the health and well-being of people worldwide by providing innovative, research-based nutritional supplements, personalized nutrition and technology-enabled medical education. Thorne is the only supplement manufacturer to collaborate with the Mayo Clinic on wellness research and content and is the proud partner of a number of U.S. National Teams, including U.S. Soccer, USA Hockey and USA Triathlon. Thorne is one of the fastest growing supplement companies and is rated the top practitioner-dispensed brand among 30 to 40 year-olds. For more information visit www.thorne.com. About WestView Capital Partners WestView Capital Partners, a Boston-based private equity firm focused exclusively on middle market growth companies, manages approximately $1.7 billion in capital across four funds. WestView partners with existing management teams to sponsor minority and majority recapitalizations, growth, and consolidation transactions in industries such as growth industrial, business services, software and IT services, healthcare technology and outsourcing, and consumer. WestView invests in companies with operating profits between $3 million and $25 million with investment sizes ranging from $15 million to $60 million. For more information, please visit www.wvcapital.com.